Skip to main content

Grafa News and Videos — Page 1088

Grafa Headlines

Latest

Grafa

RedHill Biopharma initiates enforcement of $10.9M judgment against Kukbo in Korea

RedHill Biopharma (NASDAQ:RDHL) announced on June 8, 2026, that it has officially commenced recognition and enforcement proceedings in South Korea to collect on a final judgment awarded by the New York Supreme Court against Kukbo.

Read more: RedHill Biopharma initiates enforcement of $10.9M judgment against Kukbo in Korea
Grafa

FDA expands approval of Pfizer's HYMPAVZI for hemophilia treatment

Pfizer (NYSE:PFE) announced on June 8, 2026, that the U.S. Food and Drug Administration (FDA) has granted an expanded indication for HYMPAVZI® (marstacimab-hncq). The therapy is now approved for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients 6 years of age and older with hemophilia A or B, both with and without inhibitors.

Read more: FDA expands approval of Pfizer's HYMPAVZI for hemophilia treatment

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift